Univest
Univest
  • Markets

  • 3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India

    • October 22, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi's Laboratories and Granules India

    Emerging Market and API Pharma Stocks with a strong future roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more